Literature DB >> 22717196

The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.

Gary S Wand1, Elise M Weerts, Hiroto Kuwabara, Dean F Wong, Xiaoqiang Xu, Mary E McCaul.   

Abstract

The mu opioid receptor system is altered in alcohol dependent (AD) subjects. Cortisol responses to opioid receptor antagonists are assumed to impart information about opioid receptor activity. In the present study we examined naloxone-induced cortisol responses in 18 healthy control (HC) and 25 recently detoxified AD subjects and then correlated the cortisol response with mu opioid receptor availability across 15 brain regions using positron emission tomography (PET) and the mu opioid receptor selective ligand [(11)C] Carfentanil (CFN). On average the AD subjects required twice the dose of naloxone to induce a peak cortisol response compared to the HC subjects. Using the rising slope of the cortisol curve (placebo to peak) as a metric we then went on to examine the relationship between cortisol responses to naloxone and [(11)C]CFN BP(ND). There were significant negative relationships between cortisol and [(11)C]CFN binding potential (BP(ND)) in multiple brain regions of HC subjects. However, cortisol responses did not correlate with [(11)C]CFN BP(ND) across any brain region in AD subjects. In summary, naloxone imparts information about individual differences in mu opioid receptor availability throughout the mesolimbic system in healthy individuals. However pathways governing the relationship between naloxone-induced cortisol and mu opioid receptor availability are disrupted during early abstinence in AD subjects.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22717196      PMCID: PMC3718460          DOI: 10.1016/j.alcohol.2012.04.006

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  33 in total

Review 1.  Craving for alcohol: findings from the clinic and the laboratory.

Authors:  R Sinha; S S O'Malley
Journal:  Alcohol Alcohol       Date:  1999 Mar-Apr       Impact factor: 2.826

Review 2.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

3.  Family history of alcoholism and hypothalamic opioidergic activity.

Authors:  G S Wand; D Mangold; S El Deiry; M E McCaul; D Hoover
Journal:  Arch Gen Psychiatry       Date:  1998-12

Review 4.  Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors.

Authors:  Saulo C Ribeiro; Susan E Kennedy; Yolanda R Smith; Christian S Stohler; Jon-Kar Zubieta
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-10-26       Impact factor: 5.067

5.  Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone.

Authors:  Bryon Adinoff; Steven R Krebaum; Patricia A Chandler; Wen Ye; Morton B Brown; Mark J Williams
Journal:  Alcohol Clin Exp Res       Date:  2005-04       Impact factor: 3.455

6.  Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.

Authors:  Andreas Heinz; Matthias Reimold; Jana Wrase; Derik Hermann; Bernhard Croissant; Götz Mundle; Bernhard M Dohmen; Dieter F Braus; Dieter H Braus; Gunter Schumann; Hans-Jürgen Machulla; Roland Bares; Karl Mann
Journal:  Arch Gen Psychiatry       Date:  2005-01

7.  A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA.

Authors:  K K Bucholz; R Cadoret; C R Cloninger; S H Dinwiddie; V M Hesselbrock; J I Nurnberger; T Reich; I Schmidt; M A Schuckit
Journal:  J Stud Alcohol       Date:  1994-03

8.  Naltrexone-induced alterations in human ethanol intoxication.

Authors:  R M Swift; W Whelihan; O Kuznetsov; G Buongiorno; H Hsuing
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

9.  Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men.

Authors:  G S Wand; D Mangold; M Ali
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Alcohol exposure during the developmental period induces beta-endorphin neuronal death and causes alteration in the opioid control of stress axis function.

Authors:  Dipak K Sarkar; Peter Kuhn; Jasson Marano; Cuiping Chen; Nadka Boyadjieva
Journal:  Endocrinology       Date:  2007-03-08       Impact factor: 4.736

View more
  6 in total

Review 1.  Targeted opioid receptor antagonists in the treatment of alcohol use disorders.

Authors:  Mark J Niciu; Albert J Arias
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

Review 2.  Corticotropin releasing hormone and imaging, rethinking the stress axis.

Authors:  Carlo Contoreggi
Journal:  Nucl Med Biol       Date:  2014-11-26       Impact factor: 2.408

3.  The effects of morphine, naloxone, and κ opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus).

Authors:  B J Ragen; N Maninger; S P Mendoza; K L Bales
Journal:  Neuroscience       Date:  2014-12-06       Impact factor: 3.590

Review 4.  Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

Authors:  Matthieu Colom; Benjamin Vidal; Luc Zimmer
Journal:  Front Mol Neurosci       Date:  2019-10-18       Impact factor: 5.639

Review 5.  A Survey of Molecular Imaging of Opioid Receptors.

Authors:  Paul Cumming; János Marton; Tuomas O Lilius; Dag Erlend Olberg; Axel Rominger
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

Review 6.  The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies.

Authors:  Isabell M Meier; Marie Eikemo; Siri Leknes
Journal:  Curr Addict Rep       Date:  2021-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.